With a 5-year survival rate of just about 25% across Europe, gastric cancer remains a serious health concern. Despite rising case numbers, there is still no organized screening program in the EU. Early detection is crucial, as late-stage diagnoses contribute to the high mortality rate.

The TOGAS Project is working to change this by developing innovative screening and prevention strategies, including Helicobacter pylori (H. pylori) elimination. These efforts aim to reduce gastric cancer mortality by 40%.

Learn about the recent advances in clinical practice from the article by Prof. Mārcis Leja, leading the TOGAS research group:

https://gut.bmj.com/content/early/2024/09/04/gutjnl-2024-332705

And a big thank you to other projects, EUROHELICAN and EUCanScreen, for contributing to our shared objective.

Share